COMPANY
Arcato Laboratories, Inc.
Arcato Laboratories, Inc. is listed on ClinicalTrials.gov as the lead sponsor of 1 study; the most recently updated is “A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction” (EARLY_Phase 1, recruiting), in Acute Post Operative Pain, Third Molar Extraction Surgery. Arcato Laboratories, Inc. has received NIH funding, most recently in fiscal 2022 for the project “Non-opiate topical formulations for treating pain associated with molar extractions”. From public records Source · Oct 12, 2026